Harvard Medical School professor discusses future of psychedelics
https://news.harvard.edu/gazette/story/2021/06/harvard-medical-school-professor-discusses-future-of-psychedelics/
WEBJun 10, 2021 · ROSENBAUM: The FDA [Food and Drug Administration] gave to MAPS [Multidisciplinary Association for Psychedelic Studies], which funds the study of MDMA [3,4-Methyl enedioxy methamphetamine, commonly known as ecstasy or molly], and to Compass Pathways, which is doing a Phase 2b psilocybin study, breakthrough status.
DA: 32 PA: 2 MOZ Rank: 4